We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Biobanking - Collaborating for Global R&D and Investment
Industry Insight

Biobanking - Collaborating for Global R&D and Investment

Biobanking - Collaborating for Global R&D and Investment
Industry Insight

Biobanking - Collaborating for Global R&D and Investment


Want a FREE PDF version of This Industry Insight?

Complete the form below and we will email you a PDF version of "Biobanking - Collaborating for Global R&D and Investment"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

With unquestionable commercial growth opportunities, biobanks need to deliver quality samples to create value for biomarker discovery and personalised medicine. However who should implement quality control; should biobanks be self regulating or should an independent certified organisation develop a system of accreditation?

SMi's inaugural Biobanking conference is the perfect opportunity to network with the industry's leading figures and contribute to the successful future of drug discovery. Join us at the Crowne Plaza - The City, London, on the 11th - 12th July to discuss the latest developments in the biobanking arena. Take part in this brilliant forum which aims to bridge the gap between the worlds' leading academia and the pharma industry.

One of the focal points at this conference will be the impact of drug discovery on neurology disorders. Dr Rivka Ravid, Senior Scientist, Royal Dutch Academy of Sciences, Brain Bank Consultants, will use her wealth of knowledge to inform delegates of the pitfalls and practicalities in the daily practice of Brain Banks for biomedical research.

Dr Sven Kili, Global Medical Director - Cell Therapy & Regenerative Medicine, Genzyme, provides a thorough insight regarding the application of regenerative medicine. Like most strands of medical research, the value and ultimate success of regenerative medicine in tissue engineering relies heavily on the ability to maintain quality standards in a sample collection.

The forum will also look at the operational considerations within biobanking and the need for standardisation within the various networks. George Tokiwa, Associate Scientific Director at Merck will spearhead a panel-led debate regarding the most suitable system of accreditation with use of case studies to highlight best practice between biobanks.

These are just a few of the reasons why you should attend SMi's Biobanking conference. For further information please visit the website:

http://www.smi-online.co.uk/bio-banking-event63.asp

**Keep an eye on this blog, updates to follow!**

 

Advertisement